WHO Updates Essential Medicines Lists
Introduction
The World Health Organization (WHO) continues to make strides in promoting global health with the release of updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc). The latest updates include new treatments for cancer and diabetes, addressing the growing need for effective and accessible treatments for these prevalent diseases.
Key Details
The updated EML and EMLc now include new treatments for various types of cancer, such as lung cancer, breast cancer, and melanoma. These additions aim to provide more effective and affordable treatment options for individuals diagnosed with these types of cancer. In addition, the updated lists also include new treatments for diabetes with associated comorbidities, such as heart disease, kidney disease, and neuropathy. This reflects the growing recognition of the need to address the complex and interconnected nature of chronic diseases.
Impact
The inclusion of these new treatments in the EML and EMLc has the potential to greatly impact the lives of individuals living with cancer and diabetes. Access to affordable and effective treatments can not only improve their quality of life, but also increase their chances of survival. In addition, this update serves as a reminder of the importance of continuously evaluating and updating the list of essential medicines to ensure that the needs of the global population are being met.
